Immune Therapies ( Post.Grad Dip.)
|Duration||2 years part time|
|Next Intake||September 2022|
Immune Therapy involves the manipulation of the immune system for the treatment of cancers, autoimmune disease and infection and has revolutionised the care of these diseases. The arrival of Immunotherapy has facilitated a better understanding, management, and manipulation of the immune response in both health and disease. This post graduate diploma will run in the School of Medicine, Trinity College Dublin, and is the only national part-time postgraduate course in the immunotherapy field. The Postgraduate Diploma is part-time over 2 years and comprises of taught modules covering basic, advanced, clinical and cancer immunology, immunotherapeutics, computational immunology, biostatistics, and entrepreneurship. No other programme nationally offers modules and academic experience with this defined underlying theme of Immune Therapies and Immunotherapeutics. More information can be found at www.tcd.ie/courses/postgraduate/az.
This programme is for you if:
- You are a professional in the biopharmaceutical industry seeking to acquire industry relevant knowledge in immune therapy design, manufacturing, and clinical use.
- You are a healthcare professional looking to acquire a deeper understanding of fundamental immunology and immunotherapy in relation to autoimmune diseases and cancer.
- You are seeking employment in a biopharmaceutical, medical communications, or clinical trial’s role.
Course Learning Outcomes
On successful completion of the PGDip, students should be able to:
- Discuss and critically appraise the fundamental concepts of immunology, cellular and molecular biology and its application to discovering new targets for immune therapy
- Discuss the exploitation of disease targets and immune modulation in the development of novel immunotherapeutics.
- Discuss and critically appraise the key concepts in cancer immunology and immunotherapy.
- Critically appraise the scientific and clinical challenges pertinent to immunotherapeutic design and treatment of disease.
- Appraise and evaluate the role of biomarkers, pathological indicators and imaging technologies during disease treatment.
- Discuss the exploitation of disease targets and immune modulation in the treatment of autoimmune disease and cancer.
- Evaluate and explain key concepts and processes in the field of entrepreneurship, innovation, empathy and creativity and appraise how well these apply in practice.
This course will be delivered via a blended approach.
(50% online 50% in person), but lectures will also be streamed live via Blackboard Collaborate for students who cannot attend in person
Term schedule: Semester 1 (September – December) and Semester 2 (January to May)
Lectures, workshops and assessments will be held on Thursday afternoons from 3-5pm (Standard Irish Time) and Tutorials will be held on Friday afternoons 2-3pm (Standard Irish Time) during term time.
Module 1: Fundamental Immunology (10 ECTS)
Module 2: Immunopathology & Immunotherapeutic Targets (10 ECTS)
Module 3: Advanced Immunotechnologies (5 ECTS)
Module 4: Cancer Immunology & Cancer Immunotherapeutics (5 ECTS)
Module 5: Autoimmune Disease & Immunotherapeutics (5 ECTS)
Module 6: Immunotherapeutic Related Computation and Communication (5 ECTS)
Module 7: Inflammatory & Infectious Disease Immunotherapeutics (10 ECTS)
Module 8: Innovation & Creativity in Healthcare (10 ECTS)
Modules 1-4 should be attained by students for the award of Postgraduate Certificate while Modules 1 -8 should be attained by students for the award of Postgraduate Diploma.
Course Director: Prof Cliona O’Farrelly: Chair in Comparative Immunology
Course Co-ordinator: Dr Mary Canavan: Assistant Professor in Immunology
Applicants should have a 2.1 honours degree (level 8) in any bioengineering, veterinary or biologically related degree (BSc. Honours) or be medically qualified (MB, BCh, BAO or equivalent from a recognised medical school).
Up-to-date information about course fees can be found at the Academic Registry.
For enquiries, please contact Dr Mary Canavan at email@example.com